
Opinion|Videos|July 29, 2024
Dr. O’Shaughnessy Shares Her Management Strategy for Hematologic Toxicities with Ribociclib
A medical expert navigates toxicity management in patients being treated with ribociclib.
Advertisement
Video content above is prompted by the following question(s):
- How do you monitor for and manage hematologic toxicities seen with ribociclib?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Inebilizumab for Generalized Myasthenia Gravis
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD
4
5 Key Oncology FDA Approvals From November
5








































